About RGCC
Founded by Dr. Ioannis Papasotiriou, a visionary in precision medicine and molecular oncology, RGCC stands as a world leader in cancer testing. With expertise in cancer biology, genetics, and molecular oncology, RGCC is advancing cancer care on a global scale. They has set up world-class laboratories around the globe, driving groundbreaking research and development that revolutionizes cancer treatment.
As pioneers in personalized cancer genetic tests and therapies, they’re dedicated to tailoring treatments to everyone’s unique genetic makeup. Through extensive research and development, they deliver precise, targeted solutions that improve outcomes and transform lives. RGCC’s pioneering methods are reshaping the landscape of cancer treatment, setting new standards for personalized care and innovation.